Review



anti hif 3α  (Proteintech)


Bioz Verified Symbol Proteintech is a verified supplier  
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
  • 93

    Structured Review

    Proteintech anti hif 3α
    Anti Hif 3α, supplied by Proteintech, used in various techniques. Bioz Stars score: 93/100, based on 7 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/anti hif 3α/product/Proteintech
    Average 93 stars, based on 7 article reviews
    anti hif 3α - by Bioz Stars, 2026-02
    93/100 stars

    Images



    Similar Products

    85
    Thermo Fisher gene exp hif3a mm00469375 m1
    Gene Exp Hif3a Mm00469375 M1, supplied by Thermo Fisher, used in various techniques. Bioz Stars score: 85/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/gene exp hif3a mm00469375 m1/product/Thermo Fisher
    Average 85 stars, based on 1 article reviews
    gene exp hif3a mm00469375 m1 - by Bioz Stars, 2026-02
    85/100 stars
      Buy from Supplier

    88
    Biorbyt gpx2
    Gpx2, supplied by Biorbyt, used in various techniques. Bioz Stars score: 88/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/gpx2/product/Biorbyt
    Average 88 stars, based on 1 article reviews
    gpx2 - by Bioz Stars, 2026-02
    88/100 stars
      Buy from Supplier

    93
    Proteintech anti hif 3α
    Anti Hif 3α, supplied by Proteintech, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/anti hif 3α/product/Proteintech
    Average 93 stars, based on 1 article reviews
    anti hif 3α - by Bioz Stars, 2026-02
    93/100 stars
      Buy from Supplier

    90
    Thermo Fisher anti-hif3a
    Anti Hif3a, supplied by Thermo Fisher, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/anti-hif3a/product/Thermo Fisher
    Average 90 stars, based on 1 article reviews
    anti-hif3a - by Bioz Stars, 2026-02
    90/100 stars
      Buy from Supplier

    90
    Genechem lentiviral hif3a constructs
    The associations with NSCPO risk of the three variants in discovery and replication stages
    Lentiviral Hif3a Constructs, supplied by Genechem, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/lentiviral hif3a constructs/product/Genechem
    Average 90 stars, based on 1 article reviews
    lentiviral hif3a constructs - by Bioz Stars, 2026-02
    90/100 stars
      Buy from Supplier

    90
    Genechem lentivirus hif3a overexpression
    The associations with NSCPO risk of the three variants in discovery and replication stages
    Lentivirus Hif3a Overexpression, supplied by Genechem, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/lentivirus hif3a overexpression/product/Genechem
    Average 90 stars, based on 1 article reviews
    lentivirus hif3a overexpression - by Bioz Stars, 2026-02
    90/100 stars
      Buy from Supplier

    93
    Proteintech hif3a
    The associations with NSCPO risk of the three variants in discovery and replication stages
    Hif3a, supplied by Proteintech, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/hif3a/product/Proteintech
    Average 93 stars, based on 1 article reviews
    hif3a - by Bioz Stars, 2026-02
    93/100 stars
      Buy from Supplier

    93
    Proteintech ihc staining
    The associations with NSCPO risk of the three variants in discovery and replication stages
    Ihc Staining, supplied by Proteintech, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/ihc staining/product/Proteintech
    Average 93 stars, based on 1 article reviews
    ihc staining - by Bioz Stars, 2026-02
    93/100 stars
      Buy from Supplier

    90
    Thermo Fisher taqman hif3a: hs00541709_m1; nm_022462.4;
    The associations with NSCPO risk of the three variants in discovery and replication stages
    Taqman Hif3a: Hs00541709 M1; Nm 022462.4;, supplied by Thermo Fisher, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/taqman hif3a: hs00541709_m1; nm_022462.4;/product/Thermo Fisher
    Average 90 stars, based on 1 article reviews
    taqman hif3a: hs00541709_m1; nm_022462.4; - by Bioz Stars, 2026-02
    90/100 stars
      Buy from Supplier

    Image Search Results


    The associations with NSCPO risk of the three variants in discovery and replication stages

    Journal: iScience

    Article Title: Functional variant at 19q13.3 confers nonsyndromic cleft palate susceptibility by regulating HIF3A

    doi: 10.1016/j.isci.2025.111829

    Figure Lengend Snippet: The associations with NSCPO risk of the three variants in discovery and replication stages

    Article Snippet: The lentiviral Hif3a constructs were purchased from GENECHEM (Shanghai, China).

    Techniques:

    The variant rs3826795 at 19q13.3 regulates transcriptional activity of HIF3A by modulating the binding affinity of VEZF1 to the promoter Allele-specific constructs containing the putative promoter sequence flanking rs3826795 were cloned into the pGL3-basic luciferase reporter vector and transfected into the (A) HEK-293, (B) HEPM, and (C) HOK. The results of luciferase activity were normalized to those of pGL3 basic ( n = 6). (D) EMSA with biotin-labelled oligonucleotides containing the rs3826795[A] or rs3826795[G] allele and nuclear extracts from HEPM and HOK. Lanes 1 showed the mobility of the labeled oligonucleotides without nuclear extracts; lanes 2 and 4 showed the mobility of the labeled oligonucleotides with nuclear extracts in the absence of the competitor oligonucleotide and lanes 3 and 5 showed the mobility of the labeled oligonucleotides with nuclear extracts in the presence of unlabeled competitors. The arrow indicates a DNA–protein complex. (E) In silico predicted preferential binding of VEZF1 to the non-risk allele C of rs3826795. (F) The transcription factor VEZF1 was analyzed for correlation with Hif3a in mouse embryo craniofacial tissues, lip and palate tissues, palate shelves (from left to right). (G) The ChIP enrichment of VEZF1 as determined by ChIP-qPCR. IgG was used as a negative control. (H) Supershift assays using the VEZF1 antibody in HEPM and HOK. IgG was used as a negative control. The data are presented as the means ± SD, and the p values were calculated using Student’s t test. ∗∗ indicates p < 0.01, ∗∗∗ indicates p < 0.001, and ∗∗∗∗ indicates p < 0.0001. EMSA, electrophoretic mobility shift assay; ChIP, chromatin immunoprecipitation. SD, standard deviation.

    Journal: iScience

    Article Title: Functional variant at 19q13.3 confers nonsyndromic cleft palate susceptibility by regulating HIF3A

    doi: 10.1016/j.isci.2025.111829

    Figure Lengend Snippet: The variant rs3826795 at 19q13.3 regulates transcriptional activity of HIF3A by modulating the binding affinity of VEZF1 to the promoter Allele-specific constructs containing the putative promoter sequence flanking rs3826795 were cloned into the pGL3-basic luciferase reporter vector and transfected into the (A) HEK-293, (B) HEPM, and (C) HOK. The results of luciferase activity were normalized to those of pGL3 basic ( n = 6). (D) EMSA with biotin-labelled oligonucleotides containing the rs3826795[A] or rs3826795[G] allele and nuclear extracts from HEPM and HOK. Lanes 1 showed the mobility of the labeled oligonucleotides without nuclear extracts; lanes 2 and 4 showed the mobility of the labeled oligonucleotides with nuclear extracts in the absence of the competitor oligonucleotide and lanes 3 and 5 showed the mobility of the labeled oligonucleotides with nuclear extracts in the presence of unlabeled competitors. The arrow indicates a DNA–protein complex. (E) In silico predicted preferential binding of VEZF1 to the non-risk allele C of rs3826795. (F) The transcription factor VEZF1 was analyzed for correlation with Hif3a in mouse embryo craniofacial tissues, lip and palate tissues, palate shelves (from left to right). (G) The ChIP enrichment of VEZF1 as determined by ChIP-qPCR. IgG was used as a negative control. (H) Supershift assays using the VEZF1 antibody in HEPM and HOK. IgG was used as a negative control. The data are presented as the means ± SD, and the p values were calculated using Student’s t test. ∗∗ indicates p < 0.01, ∗∗∗ indicates p < 0.001, and ∗∗∗∗ indicates p < 0.0001. EMSA, electrophoretic mobility shift assay; ChIP, chromatin immunoprecipitation. SD, standard deviation.

    Article Snippet: The lentiviral Hif3a constructs were purchased from GENECHEM (Shanghai, China).

    Techniques: Variant Assay, Activity Assay, Binding Assay, Construct, Sequencing, Clone Assay, Luciferase, Plasmid Preparation, Transfection, Labeling, In Silico, ChIP-qPCR, Negative Control, Electrophoretic Mobility Shift Assay, Chromatin Immunoprecipitation, Standard Deviation

    In vitro functional roles of HIF3A in HEPM and HOK (A–D) Quantitative analysis of cell apoptosis by flow cytometry between the two groups ( n = 6). The rate of apoptosis is lower with HIF3A knockdown and is higher than those in the corresponding negative controls in HEPM and HOK. (E and F) Photos showing the migration of HEPM and HOK with knockdown and overexpression of HIF3A in 0h, 12h, and 24h after scratch. Overexpression of HIF3A significantly reduced the migration ability in HEPM and HOK (scale bar = 200 μm). (G) Transwell assays was used to assess the migration of HEPM and HOK after transfection with HIF3A siRNAs or overexpression plasmids. The rate of migration is lower with HIF3A overexpression groups in HEPM and HOK (scale bar = 200 μm). (H) EdU proliferation analysis before or after knockdown/overexpression of HIF3A in HEPM and HOK. High HIF3A expression significantly reduced the proliferation rate of HEPM and HOK (scale bar = 200 μm). The data are presented as the means ± SD, and the p values were calculated using Student’s t test. ∗ indicates p < 0.05, ∗∗∗ indicates p < 0.001.

    Journal: iScience

    Article Title: Functional variant at 19q13.3 confers nonsyndromic cleft palate susceptibility by regulating HIF3A

    doi: 10.1016/j.isci.2025.111829

    Figure Lengend Snippet: In vitro functional roles of HIF3A in HEPM and HOK (A–D) Quantitative analysis of cell apoptosis by flow cytometry between the two groups ( n = 6). The rate of apoptosis is lower with HIF3A knockdown and is higher than those in the corresponding negative controls in HEPM and HOK. (E and F) Photos showing the migration of HEPM and HOK with knockdown and overexpression of HIF3A in 0h, 12h, and 24h after scratch. Overexpression of HIF3A significantly reduced the migration ability in HEPM and HOK (scale bar = 200 μm). (G) Transwell assays was used to assess the migration of HEPM and HOK after transfection with HIF3A siRNAs or overexpression plasmids. The rate of migration is lower with HIF3A overexpression groups in HEPM and HOK (scale bar = 200 μm). (H) EdU proliferation analysis before or after knockdown/overexpression of HIF3A in HEPM and HOK. High HIF3A expression significantly reduced the proliferation rate of HEPM and HOK (scale bar = 200 μm). The data are presented as the means ± SD, and the p values were calculated using Student’s t test. ∗ indicates p < 0.05, ∗∗∗ indicates p < 0.001.

    Article Snippet: The lentiviral Hif3a constructs were purchased from GENECHEM (Shanghai, China).

    Techniques: In Vitro, Functional Assay, Flow Cytometry, Knockdown, Migration, Over Expression, Transfection, Expressing

    Effect of Hif3a overexpression on proliferation and apoptosis in vivo (A) Schematic diagram of the mice experiment. (B) Proliferation analysis before or after overexpressing of Hif3a in E13.5d mouse palate shelves (scale bar = 100 μm). High Hif3a expression significantly reduced the proliferation rate. (C) Apoptosis analysis before or after overexpressing of Hif3a in E13.5d mouse palate shelves (scale bar = 100 μm). The rate of apoptosis is higher with Hif3a overexpression. (D) Proliferation analysis before or after overexpressing of Hif3a in E14.5d mouse palate shelves (scale bar = 100 μm). High Hif3a expression significantly reduced the proliferation rate. (E) Apoptosis analysis before or after overexpressing of Hif3a in E14.5d mouse palate shelves (scale bar = 100 μm). The rate of apoptosis is higher with Hif3a overexpression.

    Journal: iScience

    Article Title: Functional variant at 19q13.3 confers nonsyndromic cleft palate susceptibility by regulating HIF3A

    doi: 10.1016/j.isci.2025.111829

    Figure Lengend Snippet: Effect of Hif3a overexpression on proliferation and apoptosis in vivo (A) Schematic diagram of the mice experiment. (B) Proliferation analysis before or after overexpressing of Hif3a in E13.5d mouse palate shelves (scale bar = 100 μm). High Hif3a expression significantly reduced the proliferation rate. (C) Apoptosis analysis before or after overexpressing of Hif3a in E13.5d mouse palate shelves (scale bar = 100 μm). The rate of apoptosis is higher with Hif3a overexpression. (D) Proliferation analysis before or after overexpressing of Hif3a in E14.5d mouse palate shelves (scale bar = 100 μm). High Hif3a expression significantly reduced the proliferation rate. (E) Apoptosis analysis before or after overexpressing of Hif3a in E14.5d mouse palate shelves (scale bar = 100 μm). The rate of apoptosis is higher with Hif3a overexpression.

    Article Snippet: The lentiviral Hif3a constructs were purchased from GENECHEM (Shanghai, China).

    Techniques: Over Expression, In Vivo, Expressing

    Pathway analysis with overexpression of Hif3a in mouse embryo (A) Heatmap of differentially expressed genes between controls and overexpression of Hif3a . (B) Volcano plot of differentially expressed genes between controls and overexpression of Hif3a . (C) KEGG and (D) GSEA pathway enrichment analysis showed the association function of the genes reside on the susceptible region. The term/pathway were ranked by -log 10 ( P ). The relative mRNA expression levels of all differentially expressed genes in GABAergic synapse pathway were assessed by qRT-PCR with (E) HEPM and (F) HOK. The data are presented as the means ± SD, and the p values were calculated using Student’s t test. ∗ indicates p < 0.05, ∗∗ indicates p < 0.01, and ∗∗∗ indicates p < 0.001. KEGG, Kyoto encyclopedia of genes and genomes; GSEA, gene set enrichment analysis.

    Journal: iScience

    Article Title: Functional variant at 19q13.3 confers nonsyndromic cleft palate susceptibility by regulating HIF3A

    doi: 10.1016/j.isci.2025.111829

    Figure Lengend Snippet: Pathway analysis with overexpression of Hif3a in mouse embryo (A) Heatmap of differentially expressed genes between controls and overexpression of Hif3a . (B) Volcano plot of differentially expressed genes between controls and overexpression of Hif3a . (C) KEGG and (D) GSEA pathway enrichment analysis showed the association function of the genes reside on the susceptible region. The term/pathway were ranked by -log 10 ( P ). The relative mRNA expression levels of all differentially expressed genes in GABAergic synapse pathway were assessed by qRT-PCR with (E) HEPM and (F) HOK. The data are presented as the means ± SD, and the p values were calculated using Student’s t test. ∗ indicates p < 0.05, ∗∗ indicates p < 0.01, and ∗∗∗ indicates p < 0.001. KEGG, Kyoto encyclopedia of genes and genomes; GSEA, gene set enrichment analysis.

    Article Snippet: The lentiviral Hif3a constructs were purchased from GENECHEM (Shanghai, China).

    Techniques: Over Expression, Expressing, Quantitative RT-PCR

    Journal: iScience

    Article Title: Functional variant at 19q13.3 confers nonsyndromic cleft palate susceptibility by regulating HIF3A

    doi: 10.1016/j.isci.2025.111829

    Figure Lengend Snippet:

    Article Snippet: The lentiviral Hif3a constructs were purchased from GENECHEM (Shanghai, China).

    Techniques: Virus, Over Expression, Recombinant, Bicinchoninic Acid Protein Assay, Luciferase, Reporter Gene Assay, Extraction, Control, Chromatin Immunoprecipitation, In Vitro, TUNEL Assay, Sequencing, Software

    The associations with NSCPO risk of the three variants in discovery and replication stages

    Journal: iScience

    Article Title: Functional variant at 19q13.3 confers nonsyndromic cleft palate susceptibility by regulating HIF3A

    doi: 10.1016/j.isci.2025.111829

    Figure Lengend Snippet: The associations with NSCPO risk of the three variants in discovery and replication stages

    Article Snippet: Lentivirus Hif3a overexpression , GENECHEM , N/A.

    Techniques:

    The variant rs3826795 at 19q13.3 regulates transcriptional activity of HIF3A by modulating the binding affinity of VEZF1 to the promoter Allele-specific constructs containing the putative promoter sequence flanking rs3826795 were cloned into the pGL3-basic luciferase reporter vector and transfected into the (A) HEK-293, (B) HEPM, and (C) HOK. The results of luciferase activity were normalized to those of pGL3 basic ( n = 6). (D) EMSA with biotin-labelled oligonucleotides containing the rs3826795[A] or rs3826795[G] allele and nuclear extracts from HEPM and HOK. Lanes 1 showed the mobility of the labeled oligonucleotides without nuclear extracts; lanes 2 and 4 showed the mobility of the labeled oligonucleotides with nuclear extracts in the absence of the competitor oligonucleotide and lanes 3 and 5 showed the mobility of the labeled oligonucleotides with nuclear extracts in the presence of unlabeled competitors. The arrow indicates a DNA–protein complex. (E) In silico predicted preferential binding of VEZF1 to the non-risk allele C of rs3826795. (F) The transcription factor VEZF1 was analyzed for correlation with Hif3a in mouse embryo craniofacial tissues, lip and palate tissues, palate shelves (from left to right). (G) The ChIP enrichment of VEZF1 as determined by ChIP-qPCR. IgG was used as a negative control. (H) Supershift assays using the VEZF1 antibody in HEPM and HOK. IgG was used as a negative control. The data are presented as the means ± SD, and the p values were calculated using Student’s t test. ∗∗ indicates p < 0.01, ∗∗∗ indicates p < 0.001, and ∗∗∗∗ indicates p < 0.0001. EMSA, electrophoretic mobility shift assay; ChIP, chromatin immunoprecipitation. SD, standard deviation.

    Journal: iScience

    Article Title: Functional variant at 19q13.3 confers nonsyndromic cleft palate susceptibility by regulating HIF3A

    doi: 10.1016/j.isci.2025.111829

    Figure Lengend Snippet: The variant rs3826795 at 19q13.3 regulates transcriptional activity of HIF3A by modulating the binding affinity of VEZF1 to the promoter Allele-specific constructs containing the putative promoter sequence flanking rs3826795 were cloned into the pGL3-basic luciferase reporter vector and transfected into the (A) HEK-293, (B) HEPM, and (C) HOK. The results of luciferase activity were normalized to those of pGL3 basic ( n = 6). (D) EMSA with biotin-labelled oligonucleotides containing the rs3826795[A] or rs3826795[G] allele and nuclear extracts from HEPM and HOK. Lanes 1 showed the mobility of the labeled oligonucleotides without nuclear extracts; lanes 2 and 4 showed the mobility of the labeled oligonucleotides with nuclear extracts in the absence of the competitor oligonucleotide and lanes 3 and 5 showed the mobility of the labeled oligonucleotides with nuclear extracts in the presence of unlabeled competitors. The arrow indicates a DNA–protein complex. (E) In silico predicted preferential binding of VEZF1 to the non-risk allele C of rs3826795. (F) The transcription factor VEZF1 was analyzed for correlation with Hif3a in mouse embryo craniofacial tissues, lip and palate tissues, palate shelves (from left to right). (G) The ChIP enrichment of VEZF1 as determined by ChIP-qPCR. IgG was used as a negative control. (H) Supershift assays using the VEZF1 antibody in HEPM and HOK. IgG was used as a negative control. The data are presented as the means ± SD, and the p values were calculated using Student’s t test. ∗∗ indicates p < 0.01, ∗∗∗ indicates p < 0.001, and ∗∗∗∗ indicates p < 0.0001. EMSA, electrophoretic mobility shift assay; ChIP, chromatin immunoprecipitation. SD, standard deviation.

    Article Snippet: Lentivirus Hif3a overexpression , GENECHEM , N/A.

    Techniques: Variant Assay, Activity Assay, Binding Assay, Construct, Sequencing, Clone Assay, Luciferase, Plasmid Preparation, Transfection, Labeling, In Silico, ChIP-qPCR, Negative Control, Electrophoretic Mobility Shift Assay, Chromatin Immunoprecipitation, Standard Deviation

    In vitro functional roles of HIF3A in HEPM and HOK (A–D) Quantitative analysis of cell apoptosis by flow cytometry between the two groups ( n = 6). The rate of apoptosis is lower with HIF3A knockdown and is higher than those in the corresponding negative controls in HEPM and HOK. (E and F) Photos showing the migration of HEPM and HOK with knockdown and overexpression of HIF3A in 0h, 12h, and 24h after scratch. Overexpression of HIF3A significantly reduced the migration ability in HEPM and HOK (scale bar = 200 μm). (G) Transwell assays was used to assess the migration of HEPM and HOK after transfection with HIF3A siRNAs or overexpression plasmids. The rate of migration is lower with HIF3A overexpression groups in HEPM and HOK (scale bar = 200 μm). (H) EdU proliferation analysis before or after knockdown/overexpression of HIF3A in HEPM and HOK. High HIF3A expression significantly reduced the proliferation rate of HEPM and HOK (scale bar = 200 μm). The data are presented as the means ± SD, and the p values were calculated using Student’s t test. ∗ indicates p < 0.05, ∗∗∗ indicates p < 0.001.

    Journal: iScience

    Article Title: Functional variant at 19q13.3 confers nonsyndromic cleft palate susceptibility by regulating HIF3A

    doi: 10.1016/j.isci.2025.111829

    Figure Lengend Snippet: In vitro functional roles of HIF3A in HEPM and HOK (A–D) Quantitative analysis of cell apoptosis by flow cytometry between the two groups ( n = 6). The rate of apoptosis is lower with HIF3A knockdown and is higher than those in the corresponding negative controls in HEPM and HOK. (E and F) Photos showing the migration of HEPM and HOK with knockdown and overexpression of HIF3A in 0h, 12h, and 24h after scratch. Overexpression of HIF3A significantly reduced the migration ability in HEPM and HOK (scale bar = 200 μm). (G) Transwell assays was used to assess the migration of HEPM and HOK after transfection with HIF3A siRNAs or overexpression plasmids. The rate of migration is lower with HIF3A overexpression groups in HEPM and HOK (scale bar = 200 μm). (H) EdU proliferation analysis before or after knockdown/overexpression of HIF3A in HEPM and HOK. High HIF3A expression significantly reduced the proliferation rate of HEPM and HOK (scale bar = 200 μm). The data are presented as the means ± SD, and the p values were calculated using Student’s t test. ∗ indicates p < 0.05, ∗∗∗ indicates p < 0.001.

    Article Snippet: Lentivirus Hif3a overexpression , GENECHEM , N/A.

    Techniques: In Vitro, Functional Assay, Flow Cytometry, Knockdown, Migration, Over Expression, Transfection, Expressing

    Effect of Hif3a overexpression on proliferation and apoptosis in vivo (A) Schematic diagram of the mice experiment. (B) Proliferation analysis before or after overexpressing of Hif3a in E13.5d mouse palate shelves (scale bar = 100 μm). High Hif3a expression significantly reduced the proliferation rate. (C) Apoptosis analysis before or after overexpressing of Hif3a in E13.5d mouse palate shelves (scale bar = 100 μm). The rate of apoptosis is higher with Hif3a overexpression. (D) Proliferation analysis before or after overexpressing of Hif3a in E14.5d mouse palate shelves (scale bar = 100 μm). High Hif3a expression significantly reduced the proliferation rate. (E) Apoptosis analysis before or after overexpressing of Hif3a in E14.5d mouse palate shelves (scale bar = 100 μm). The rate of apoptosis is higher with Hif3a overexpression.

    Journal: iScience

    Article Title: Functional variant at 19q13.3 confers nonsyndromic cleft palate susceptibility by regulating HIF3A

    doi: 10.1016/j.isci.2025.111829

    Figure Lengend Snippet: Effect of Hif3a overexpression on proliferation and apoptosis in vivo (A) Schematic diagram of the mice experiment. (B) Proliferation analysis before or after overexpressing of Hif3a in E13.5d mouse palate shelves (scale bar = 100 μm). High Hif3a expression significantly reduced the proliferation rate. (C) Apoptosis analysis before or after overexpressing of Hif3a in E13.5d mouse palate shelves (scale bar = 100 μm). The rate of apoptosis is higher with Hif3a overexpression. (D) Proliferation analysis before or after overexpressing of Hif3a in E14.5d mouse palate shelves (scale bar = 100 μm). High Hif3a expression significantly reduced the proliferation rate. (E) Apoptosis analysis before or after overexpressing of Hif3a in E14.5d mouse palate shelves (scale bar = 100 μm). The rate of apoptosis is higher with Hif3a overexpression.

    Article Snippet: Lentivirus Hif3a overexpression , GENECHEM , N/A.

    Techniques: Over Expression, In Vivo, Expressing

    Pathway analysis with overexpression of Hif3a in mouse embryo (A) Heatmap of differentially expressed genes between controls and overexpression of Hif3a . (B) Volcano plot of differentially expressed genes between controls and overexpression of Hif3a . (C) KEGG and (D) GSEA pathway enrichment analysis showed the association function of the genes reside on the susceptible region. The term/pathway were ranked by -log 10 ( P ). The relative mRNA expression levels of all differentially expressed genes in GABAergic synapse pathway were assessed by qRT-PCR with (E) HEPM and (F) HOK. The data are presented as the means ± SD, and the p values were calculated using Student’s t test. ∗ indicates p < 0.05, ∗∗ indicates p < 0.01, and ∗∗∗ indicates p < 0.001. KEGG, Kyoto encyclopedia of genes and genomes; GSEA, gene set enrichment analysis.

    Journal: iScience

    Article Title: Functional variant at 19q13.3 confers nonsyndromic cleft palate susceptibility by regulating HIF3A

    doi: 10.1016/j.isci.2025.111829

    Figure Lengend Snippet: Pathway analysis with overexpression of Hif3a in mouse embryo (A) Heatmap of differentially expressed genes between controls and overexpression of Hif3a . (B) Volcano plot of differentially expressed genes between controls and overexpression of Hif3a . (C) KEGG and (D) GSEA pathway enrichment analysis showed the association function of the genes reside on the susceptible region. The term/pathway were ranked by -log 10 ( P ). The relative mRNA expression levels of all differentially expressed genes in GABAergic synapse pathway were assessed by qRT-PCR with (E) HEPM and (F) HOK. The data are presented as the means ± SD, and the p values were calculated using Student’s t test. ∗ indicates p < 0.05, ∗∗ indicates p < 0.01, and ∗∗∗ indicates p < 0.001. KEGG, Kyoto encyclopedia of genes and genomes; GSEA, gene set enrichment analysis.

    Article Snippet: Lentivirus Hif3a overexpression , GENECHEM , N/A.

    Techniques: Over Expression, Expressing, Quantitative RT-PCR

    Journal: iScience

    Article Title: Functional variant at 19q13.3 confers nonsyndromic cleft palate susceptibility by regulating HIF3A

    doi: 10.1016/j.isci.2025.111829

    Figure Lengend Snippet:

    Article Snippet: Lentivirus Hif3a overexpression , GENECHEM , N/A.

    Techniques: Virus, Over Expression, Recombinant, Bicinchoninic Acid Protein Assay, Luciferase, Reporter Gene Assay, Extraction, Control, Chromatin Immunoprecipitation, In Vitro, TUNEL Assay, Sequencing, Software